APR 30, 2015 7:34 AM PDT

New Mechanism Found to Control Cell Response to DNA Damage

WRITTEN BY: Judy O'Rourke
DNA can be damaged by different environmental insults, such as ultraviolet light, ionizing radiation, oxidative stress or certain drugs.

If the DNA is not repaired, cells may begin growing uncontrollably, leading to the development of cancer. Therefore, cells must maintain an intricate regulatory network to ensure that their DNA remains intact. Moffitt Cancer Center researchers have discovered a novel mechanism that controls a cell's response to DNA damage.

The protein SIRT1 plays an important role in controlling DNA damage. It can sense the presence of DNA damage, signal to other proteins that damage exists, aid in the repair of damage and stimulate cell death if the damage cannot be repaired.

Moffitt researchers found that SIRT1 is modified by a process called ubiquitination, in which a small residue called ubiquitin is added to SIRT1. This modification allows SIRT1 to relay information about DNA damage to other proteins, leading to either DNA repair or cell death.

The researchers performed studies to determine how ubiquitin modification changes SIRT1 function. They discovered that cells respond to ubiquitin modification of SIRT1 differently according to the type of environmental insult that occurs. If cells are exposed to a drug called etoposide, SIRT1 ubiquitination blocks cell death. However, if cells are exposed to oxidative stress, SIRT1 ubiquitination promotes cell death.

These results are important because they increase scientists' understanding of how proteins and cells function, potentially leading to more effective therapeutic drugs in the future.

"SIRT1 is known to be abnormally expressed in a variety of cancers and might be a good target for therapy," says Ed Seto, PhD, senior member, Cancer Biology and Evolution Program, Moffitt. "Ubiquitin-proteasome inhibitors have already been successfully used in cancer therapy and clinical trials. Therefore, this research might provide molecular bases and insights for developing additional therapeutic strategies in the future."

The research, in an article titled "Ubiquitinated Sirtuin 1 (SIRT1) Function Is Modulated during DNA Damage-induced Cell Death and Survival," was published in The Journal of Biological Chemistry.

[Source: Moffitt Cancer Center]
About the Author
  • Judy O'Rourke worked as a newspaper reporter before becoming chief editor of Clinical Lab Products magazine. As a freelance writer today, she is interested in finding the story behind the latest developments in medicine and science, and in learning what lies ahead.
You May Also Like
FEB 08, 2021
Microbiology
Fecal Transplants May Improve Cancer Treatment Efficacy
FEB 08, 2021
Fecal Transplants May Improve Cancer Treatment Efficacy
Humans carry around trillions of microbes, and the ones in our guts - the gut microbiome - plays an essential role in ou ...
MAR 02, 2021
Immunology
Another Trick up Tumors' Sleeves Exposed
MAR 02, 2021
Another Trick up Tumors' Sleeves Exposed
Tumors have sneaky strategies for establishing themselves within healthy tissues, flourishing in plain sight of circulat ...
MAR 11, 2021
Cancer
Placenta structure resembles that of tumors
MAR 11, 2021
Placenta structure resembles that of tumors
Research published yesterday in the journal Nature provides further insight into how the placenta differs from other hum ...
MAR 22, 2021
Clinical & Molecular DX
Good Dog! Man's Best Friend Sniffs Out Prostate Cancer.
MAR 22, 2021
Good Dog! Man's Best Friend Sniffs Out Prostate Cancer.
Trained dogs can spot aggressive prostate cancers by detecting trace amounts of chemical biomarkers in urine samples, sa ...
MAR 30, 2021
Immunology
Single-Cell Technology Exposes Melanoma's Weak Spot
MAR 30, 2021
Single-Cell Technology Exposes Melanoma's Weak Spot
The immune system encompasses a powerful arsenal of weapons against pathogenic threats. But what stops healthy tissues i ...
APR 14, 2021
Cancer
Fighting back against medulloblastoma with naturally-occurring compound
APR 14, 2021
Fighting back against medulloblastoma with naturally-occurring compound
Renewed hope for young children with medulloblastoma comes in the form of a research paper published from the Queen Mary ...
Loading Comments...